James C. Blair, Director at Clovis Oncology, holds 63.54K shares in Clovis Oncology (Ticker: CLVSQ), holds ― shares in aTyr Pharma (Ticker: LIFE), holds 0.00 shares in Cadence Pharma (Ticker: CADX). Most recently, James C. Blair Bought ― shares of Clovis Oncology on Aug 20, 2019 for an estimated value of 233.40K.
What is the percentage of profitable transactions made by James C. Blair?
The percentage of profitable transactions made by James C. Blair is 75%.
What is the average return per transaction made by James C. Blair?
The average return per transaction made by James C. Blair is 48.90%.
What stocks does James C. Blair hold?
James C. Blair holds: CLVSQ, LIFE, OCRX, CLPM, ZGNX, ~ACHN, ESPR, TBRA, SNMX, VNDA, AKAOQ, NUVA, VCYT, DRNA, OREXQ, ALIM, EVOK, CADX, SNTS, SOMX, PRTK, VOLC, DRTX stocks.
What was James C. Blair’s latest transaction?
James C. Blair latest transaction was an Informative Buy of $233.40K.
What was James C. Blair's most profitable transaction?
James C. Blair’s most profitable transaction was an Informative Sell of CLVSQ stock on March 18, 2019. The return on the trade was 78.00%.
What is James C. Blair's role in Clovis Oncology?
James C. Blair's role in Clovis Oncology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.